Enrollment is now open for our Digital Health Executive Leadership Program.

Reformulate Health
  • Home
  • About Us
  • Leadership
  • Startups
  • Life Sciences
  • Healthcare
  • Investors
  • Insights
  • More
    • Home
    • About Us
    • Leadership
    • Startups
    • Life Sciences
    • Healthcare
    • Investors
    • Insights
Reformulate Health
  • Home
  • About Us
  • Leadership
  • Startups
  • Life Sciences
  • Healthcare
  • Investors
  • Insights

WE DELIVER ON THE STORY, ENERGY, PARTNERSHIPS AND DEAL FLOW

to extend your reach and impact.

PRIVATE EQUITY, VC AND FAMILY OFFICE

Investors PE VC

Due Diligence

We work with leading private equity and venture capital investors globally, leveraging our deep life sciences & healthcare experience, knowledge and industry connections to commercially assess potential investment opportunities. Our due diligences are thorough, highly analytical and rooted in ensuring the most robust and impactful investments are selected. 


Coverage can include: 

  • Competitive landscape
  • Company positioning 
  • Market size and growth
  • Growth opportunities
  • Regulatory environment
  • Risks

TRANSFORMATIVE HEALTHCARE Sector Reviews

As new technological paradigms mature and value propositions shift to drive long-term healthcare value and impact, it is critical that private equity and venture capital stays at the forefront of industry shifts and changes. We help clients to become and stay deeply immersed in the current state of the industry and where it is heading, allowing them to be ahead of the curve when identifying and assessing targets.


Coverage can include:

  • Competitive landscape
  • Market size and growth
  • Industry dynamics and drivers
  • Emerging technologies 
  • Growth opportunities 
  • Regulatory environment
  • Risks 

Strategy

Generating the highest value from investments in life sciences and healthcare involves identifying and developing scalable solutions that enhance the therapeutic area top line across the drug value chain or improve the efficiency & quality of patient services. We help private equity and venture capital investors transform current investments into leading pharma, medtech, biotech, healthcare, digital health companies. 


Strategic services offered include: 

  • Digital strategy
  • Sales transformation
  • Product launch 
  • Market entry 
  • Pricing strategy
  • Sustainability plan

Proactive Deal Generation

Our deep life sciences & healthcare experience, knowledge and industry connections allows private equity and venture capital investors to stay ahead of the curve and proactively identify potential targets before a formal deal process is initiated.


For example: 

  • Target identification 
  • Establishing contact with targets 

ENTREPRENEUR IN RESIDENCE

The ability to embed external thinking, experience, and urgency in execution into your portfolio in an agile and dynamic manner is key to scalable & sustainable growth. At Reformulate, we can provide you with experienced entrepreneurs and industry executives who are ‘entrepreneurs in residence’ across your portfolio. Our ‘entrepreneur in residence’ will form a key part of your team for a period as short or as long as needed, with the goal of mentoring and coaching your portfolio founders and executives, to accelerate time-to-value for your investments. 

Digital health maturity of the US Biopharmaceutical industry

In this JMIR publication Dr Ramin Rafiei and Dr Timothy Aungst measure the digital health maturity of the top 15 biopharmaceutical companies in the US biologics market and establish the framework for next-generation autoinjectable devices powering home-based precision care.

READY TO REFORMULATE HEALTH?

WE ARE KEEN TO TALK TO ANYONE WHO WANTS TO BRING THE HEALTHCARE OF TOMORROW TO LIFE

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAY CURRENT WITH OUR LATEST INSIGHTS

© Reformulate Health

Sydney | New York

  • Home
  • Leadership
  • Startups
  • Life Sciences
  • Healthcare
  • Investors
  • Insights